Table 3.

Vitamin D supplementation in children with obesity and NAFLD.

Reference	Population	Duration	Treatment	Results
El Amrousy et al., 2021 [131]	100 children with biopsy-proven NAFLD	6 months	Group 1: treatment group (2000 IU/day of vitamin D) Group 2: placebo group	Improvements in hepatic steatosis and lobular inflammation by liver biopsy and a decrease in AST, ALT, triglycerides, LDL, fasting insulin, and glycemia and HOMA-IR were observed. Moreover, vitamin D levels and HDL cholesterol significantly increased in the treated group.